Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-1,800
Closed -$25K 6369
2019
Q4
$25K Sell
1,800
-200
-10% -$2.93K ﹤0.01% 5927
2019
Q3
$33K Sell
2,000
-200
-9% -$3.43K ﹤0.01% 6082
2019
Q2
$35K Sell
2,200
-10,000
-82% -$180K ﹤0.01% 6238
2019
Q1
$212K Buy
12,200
+3,900
+47% +$56.2K ﹤0.01% 4776
2018
Q4
$92K Buy
+8,300
New +$116K ﹤0.01% 5095
2018
Q3
Sell
-600
Closed -$11K 7317
2018
Q2
$11K Sell
600
-7,800
-93% -$135K ﹤0.01% 6506
2018
Q1
$94K Buy
8,400
+7,200
+600% +$101K ﹤0.01% 5431
2017
Q4
$23K Buy
1,200
+1,000
+500% +$18.8K ﹤0.01% 6231
2017
Q3
$4K Hold
200
﹤0.01% 6494
2017
Q2
$4K Hold
200
﹤0.01% 6298
2017
Q1
$3K Buy
+200
New +$2.19K ﹤0.01% 6393

Other funds holding OMER

Barclays's OMER Position: Q1 2026 in Review

Barclays reduced its Omeros (OMER) stake by 63% in Q1 2026, selling an estimated $890K and leaving 44,922 shares worth $474K. The position accounts for ﹤0.01% of the portfolio, ranked #3218.

Barclays first reported a position in OMER in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.07M in Q4 2025. 161 funds tracked by Wall St. Rank hold OMER as of Q1 2026.

  • Barclays held 44,922 shares of Omeros worth $474K as of Q1 2026.
  • Barclays sold 75,568 Omeros shares in Q1 2026, an estimated $890K.
  • Omeros made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3218 holding.
  • Barclays first reported a position in Omeros in Q2 2013 and has held it in 52 quarters since.
  • Barclays's Omeros position peaked at $2.07M in Q4 2025.
  • 161 funds tracked by Wall St. Rank held Omeros as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.